High-throughput Screening Integration
High-Throughput Screening Integration is a methodological framework that systematically incorporates high-throughput screening data into Adverse Outcome Pathway development by enabling the rapid identification and prioritization of molecular initiating events and key events through automated, large-scale chemical testing.
26
Publications
1.7K
Citations
161
Authors
49
Institutions
Publications per year
2017–2026
10
Parents
26
High-Throughput Screening: Update on Practices and Success
Sandra Fox, Shauna Farr-Jones, Lynne Sopchak et al. · SLAS DISCOVERY · 2006 · 216 citations · Full text
Ravi Kapur, Kenneth A. Giuliano, Martha Campana et al. · Biomedical Microdevices · 1999 · 73 citations
1–5 of 26
161
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 161
49
Harvard University
Cambridge, United States
5 h-index
26 publications
1.6K citations

Broad Institute
Cambridge, United States
3 h-index
29 publications
6.8K citations

Boston Children's Hospital
Boston, United States
2 h-index
2 publications
486 citations
National University of Singapore
Singapore, Singapore
2 h-index
2 publications
142 citations
University of Pittsburgh
Pittsburgh, United States
2 h-index
20 publications
888 citations
ShanghaiTech University
Shanghai, China
2 h-index
2 publications
142 citations
Bristol-Myers Squibb (United States)
New York, United States
2 h-index
6 publications
216 citations
Discovery Institute
Seattle, United States
2 h-index
17 publications
753 citations
1–8 of 49
6 publications · 460 citations
6
h-index
2 publications · 119 citations
2
h-index
2 publications · 72 citations
2
h-index
2 publications · 48 citations
2
h-index
1 publications · 19 citations
1
h-index
1–5